Welcome to our dedicated page for Sunlink Hlth news (Ticker: SSY), a resource for investors and traders seeking the latest updates and insights on Sunlink Hlth stock.
SunLink Health Systems, Inc. (formerly NYSE American: SSY) generated a stream of news focused on its pharmacy-centered healthcare operations in the Southeast and, ultimately, its corporate combination with Regional Health Properties, Inc. News coverage for SSY traces the company’s evolution from operating hospital and long-term care assets in Mississippi to concentrating on a pharmacy business, while pursuing an extraordinary transaction to reshape its scale and capital structure.
Company press releases detail quarterly financial results in which consolidated net revenues consisted primarily of pharmacy net revenues, with commentary on institutional pharmacy activity, retail pharmacy scripts, and durable medical equipment orders. These earnings updates also discuss the impact of asset sales, such as the divestiture of Trace Regional Hospital operations, the sale of a senior care facility in Houston, Mississippi, and the sale of the Trace Regional Hospital real estate, all framed as part of a broader repositioning strategy.
A major theme in SunLink’s later news flow is the merger with Regional Health Properties, Inc. Announcements describe the entry into a definitive merger agreement, subsequent amendments extending the termination date, and the rationale for combining SunLink’s pharmacy operations with Regional’s nursing home and healthcare real estate portfolio. Press releases outline shareholder meetings, proxy voting updates, recommendations from the SunLink board, and the eventual approval of the merger by SunLink and Regional shareholders.
Additional news items cover a special cash dividend declared prior to the merger, explanations of due bill procedures for that dividend, and a notice from NYSE American that SunLink had fallen below certain continued listing standards due to not holding an annual meeting within a specified fiscal year. The culmination of this news timeline is the announcement, referenced in SunLink’s Form 8-K, that the merger with Regional closed on August 14, 2025.
This news page serves as an archive of SunLink’s historical announcements, financial updates, and merger-related communications for investors analyzing the path that led from SSY as an independent healthcare and pharmacy company to its integration into Regional Health Properties, Inc.
SunLink Health Systems (NYSE American: SSY) reported financial results for Q4 and FY 2024. Key highlights include:
- Q4 loss from continuing operations: $652,000 ($0.09 per share)
- Q4 earnings from discontinued operations: $4,940,000 ($0.70 per share)
- Q4 net income: $4,288,000 ($0.61 per share)
- FY 2024 loss from continuing operations: $2,311,000 ($0.33 per share)
- FY 2024 net loss: $1,527,000 ($0.22 per share)
- Sale of Trace Extended Care & Rehab for $6,522,000, with a gain of $5,584,000
- Revised agreement for sale of Trace Hospital Assets
- Consolidated net revenues for Q4: $7,913,000
- Consolidated net revenues for FY 2024: $32,440,000
The company continues to experience adverse effects from the COVID-19 pandemic, including workforce shortages and inflationary pressures.
SunLink Health Systems (NYSE:AMERICAN: SSY) announced the sale of its Trace Extended Care & Rehab facility in Houston, Mississippi, for approximately $7,100,000.
The net proceeds of about $6,500,000 will be used for working capital and general corporate purposes.
The company expects a pre-tax gain of approximately $5,700,000 in its fourth fiscal quarter ending June 30, 2024.
This sale aligns with SunLink's strategy to position itself for potential extraordinary transactions like mergers or consolidations, while also improving existing operations and disposing of non-performing assets.
SunLink Health Systems (NYSE American: SSY) reported a significant increase in losses for its third fiscal quarter ended March 31, 2024. The loss from continuing operations was $824,000 (or $0.12 per share), up from $453,000 (or $0.06 per share) in the same period last year. Net loss for the quarter was $1,396,000 (or $0.20 per share), compared to $762,000 (or $0.11 per share) last year.
This quarter's results included a $572,000 loss from discontinued operations, primarily due to a $613,000 loss on the sale of Trace Regional Hospital and associated properties.
Consolidated net revenues dropped to $7,462,000 from $8,181,000, mainly due to a 9% decrease in pharmacy net revenues. Operating loss increased to $853,000 from $467,000. The nine months ended March 31, 2024, also showed a higher net loss of $5,815,000 (or $0.83 per share), compared to $369,000 (or $0.05 per share) last year.
SunLink also reported ongoing challenges from COVID-19, including workforce shortages and inflationary pressures.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.